A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers

By Krishnan Suma M.   Stark Jeffrey G.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

Single‐dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate‐release and hydrophilic matrix extended‐release tablets in healthy Japanese subjects without co‐administration of an opioid antagonist

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 975-984

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 6, 2015-06 ,pp. : 680-687

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single‐dose Auron Misheil therapy in healthy male subjects

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 3-11

John Wiley & Sons Inc

Access to resources Recommend Favorite